ECRM_1170x120_8-1-17

Glenmark gets okay for generic acne solution

Print Friendly, PDF & Email
PARAMUS, N.J. – Glenmark Pharmaceuticals has received the Food and Drug Administration’s approval for generic BenzaClin (clindamycin and benzoyl peroxide gel, 1%/5%).

The product, which is an acne treatment, is a generic of Valeant Bermuda’s branded product.

BenzaClin gel, 1%/5% had a market value of approximately $99.4 million for the 12 month period ended January 2019, according to IQVIA.


NT_728x90_10-3-18

INNOV_728x90_8-1-17

Comments are closed.